维普期刊资源整合服务平台（V6.5）

28篇 您的检索式：作者名="Lutz MP"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Docetaxel plus gemcitabine or docetaxel plus cisplatin in advanced pancreatic carcinoma: randomized phase Ⅱ study 40984 of the European Organisation for Research and Treatment of Cancer Gastrointestinal Group 显示文摘	Lutz MP Van Cutsem E Wagener T	2005	J Clin Oncol2005，23，36：	1
2	Overexpression and activation of the tyrosine kinase Src in human pancreatic carcinoma显示文摘	Lutz MP Esser IB Flossmann-Kast BB	1998	Biochem Biophys Res Commun1998，243，2：	1
3	Systemic chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer显示文摘	Folprecht G Kohne CH Lutz MP	2007	Cancer Treat Res2007，134，：	1
4	Cetuximab and irinote-can/5-fluorouracil/folinic acid is a safe combination for the first-line treatment of patients with epidermal growth factor receptor expressing metastatic colorectal carcinoma显示文摘	Folprecht G Lutz MP Sch(o)ffski P	2006	Ann Oncol2006，17，3：	1
5	Cetuximab andirinotecan/5-fluorouracil/folinic acid is a safe combination for the firstline treatment of patients with epidermal growth factor receptor expressing metastatic colorectal carcinoma 显示文摘	Folprecht G Lutz MP Schoffski P	2006	Ann Oncol2006，17，3：	1
6	Current treatment concepts for the chemotherapy of pancreatic carcinoma 显示文摘	Lutz MP	2003	Dtsch Med Wochenschr2003，，2：	1
7	Presence of high levels of MT1- MMP protein in fibroblastic cells of human invasive carcinomas 显示文摘	Lutz Y Mechine- Neuville A	1999	Int J Cancer1999，82，2：	1
8	Presence of high levels of MT1-MMP protein in fibroblastic cells of human invasive carcinomas显示文摘	Chenard MP Lutz Y Mechine-Neuville A	1999	Int J Cancer1999，，2：	1
9	Cetuximab and irinotecan/5-fluorouracil/folinic acid is a safe combination for the first-line treatment of patients with Cetuximab/FOLFOX-4 in the treatment of mCRC epidermal growth factor receptor expressing metastatic colorectal carcinoma 显示文摘	Folprecht G Lutz MP Schoffski P	2006	Ann Oncol2006，17，：	1
10	Preinsulin stimulates growth of small intestinal crypt-like cells acting via specific receptors显示文摘	Jehle PM Fussgacnger RD Angelus NK Jungwirth ILl Saile B Lutz MP	1999	Am J Physiol1999，276，21：	1
11	Cetuximab and irinotecan/5-fluorouracil/folinic acid is a safe combination for the firstline treatment of patients with epidermal growth factor receptor expressing metastatic colorectal carcinoma显示文摘	Folprecht G Lutz MP Schoffski P	2006	Ann Oncol2006，17，3：	1
12	Cyclic AMP induces transactivation of the receptors for epidermal growth factor and never growth factor, thereby modulating activation of MAP kinase, Akt, and neurite outgrowth in PC12 cells 显示文摘	Piiper A Dikic I Lutz MP	2002	J Biol Chem2002，277，43：	1
13	Cetuximab and irinotecan/ 5 - fluorouraeil/folinic acid is a safe combination for the first - line treatment of patients frith epidermal growth factor receptor expressing metastatic coloreetal carcinoma 显示文摘	Folprecht G Lutz MP Schiffski P	2006	Ann Oncol2006，17，：	1
14	Presence of high levels of MT1 - MMP protein in fibroblastic cells of human invasive carcinomas显示文摘	Chenard MP Lutz Y Mechine Neuville A	1999	Int J Cancer1999，82，2：	1
15	Cetuximab and irinotecan/5-fluorouracil/folinic acid is a safe combination for the first-line treatment of patients with epidermal growth factor receptor expressing metastatic colorectal Carcinoma显示文摘	Folprecht G Lutz MP Schoffski P	2006	Ann Oncol2006，17，3：	1
16	Cetuximab and irinotecan/5-fluorouracil/folinic acid is a safe combination for the first-line treatment of patients with epidermal growth factor receptor expressing metastatic colorectal carcinoma显示文摘	Folprecht G Lutz MP Schoffski P	2006	Ann Oncol2006，17，3：	1
17	Treatment Decisions in Palliative Cancer Care: Patients' Preferences for Involvement and Doctors Knowledge About it显示文摘	Rothenbacher D Lutz MP Porzsolt F	1997	European Journal of Cancer1997，33，8：	1
18	Presence of high levels of MT1-MMP protein in fibroblastic cells of human invasive carcinomas显示文摘	Chenard MP Lutz Y Mechine-Neuville A	1999	Int J Cancer1999，19，829：	1
19	Cetuximab and irinotecan/5-fluorouracil/folinic acid is a safe combination for the First-line treatment of patientswith epidermal growth factor receptor expressing metastatic colorectal carcinoma 显示文摘	Folprecht G Lutz MP Schoffski P	2006	Ann Oncol2006，17，3：	1
20	The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases 显示文摘	Phillips RJ Burdick MD Lutz M Belperio JA Keane MP Strieter RM	2003	Am J Respir Crit Care Med2003，167，12：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示